Hsiao CF - Search Results

1

Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials.

Liu JT, Tsou HH, Gordon Lan KK, Chen CT, Lai YH, Chang WJ, Tzeng CS, Hsiao CF. Liu JT, et al. Among authors: hsiao cf. Stat Med. 2016 Jun 30;35(14):2301-14. doi: 10.1002/sim.6869. Epub 2016 Feb 2. Stat Med. 2016. PMID: 26833851

2

A group sequential approach to evaluation of bridging studies.

Hsiao CF, Xu JZ, Liu JP. Hsiao CF, et al. J Biopharm Stat. 2003 Nov;13(4):793-801. doi: 10.1081/BIP-120024210. J Biopharm Stat. 2003. PMID: 14584723

3

A two-stage design for bridging studies.

Hsiao CF, Xu JZ, Liu JP. Hsiao CF, et al. J Biopharm Stat. 2005;15(1):75-83. doi: 10.1081/bip-200040836. J Biopharm Stat. 2005. PMID: 15702606

4

Use of prior information for Bayesian evaluation of bridging studies.

Hsiao CF, Hsu YY, Tsou HH, Liu JP. Hsiao CF, et al. J Biopharm Stat. 2007;17(1):109-21. doi: 10.1080/10543400601001501. J Biopharm Stat. 2007. PMID: 17219758

5

Mixed noninferiority margin and statistical tests in active controlled trials.

Tsou HH, Hsiao CF, Chow SC, Yue L, Xu Y, Lee S. Tsou HH, et al. Among authors: hsiao cf. J Biopharm Stat. 2007;17(2):339-57. doi: 10.1080/10543400601183861. J Biopharm Stat. 2007. PMID: 17365228

6

Translation in different diagnostic procedures---traditional Chinese medicine and Western medicine.

Hsiao CF, Tsou HH, Wu YJ, Lin CH, Chang YJ. Hsiao CF, et al. J Formos Med Assoc. 2008 Dec;107(12 Suppl):74-85. doi: 10.1016/s0929-6646(09)60011-5. J Formos Med Assoc. 2008. PMID: 19129048 Free article.

7

An alternative phase II/III design for continuous endpoints.

Huang WS, Liu JP, Hsiao CF. Huang WS, et al. Among authors: hsiao cf. Pharm Stat. 2011 Mar-Apr;10(2):105-14. doi: 10.1002/pst.418. Pharm Stat. 2011. PMID: 20186724

8

Sample size determination for a specific region in a multiregional trial.

Ko FS, Tsou HH, Liu JP, Hsiao CF. Ko FS, et al. Among authors: hsiao cf. J Biopharm Stat. 2010 Jul;20(4):870-85. doi: 10.1080/10543401003618900. J Biopharm Stat. 2010. PMID: 20496211

9

Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspective.

Tsou HH, Chow SC, Lan KK, Liu JP, Wang M, Chern HD, Ho LT, Hsiung CA, Hsiao CF. Tsou HH, et al. Among authors: hsiao cf. Pharm Stat. 2010 Jul-Sep;9(3):201-6. doi: 10.1002/pst.442. Pharm Stat. 2010. PMID: 20568264

10

CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.

Lin KM, Tsou HH, Tsai IJ, Hsiao MC, Hsiao CF, Liu CY, Shen WW, Tang HS, Fang CK, Wu CS, Lu SC, Kuo HW, Liu SC, Chan HW, Hsu YT, Tian JN, Liu YL. Lin KM, et al. Among authors: hsiao mc, hsiao cf. Pharmacogenomics. 2010 Nov;11(11):1535-43. doi: 10.2217/pgs.10.128. Pharmacogenomics. 2010. PMID: 21121774 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters